Skip to main navigation Skip to search Skip to main content

O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait

    • Novo Nordisk Foundation
    • Thumbay hospital Ajman
    • Dubai Diabetes Center
    • Medcare Hospital
    • NMC Hospital
    • Oriana Hospital
    • Al Garhoud private hospital

    Project: Clinical Trial

    Project Details

    Description

    The purpose of the study is to look at the change in blood sugar levels in people with type 2 diabetes who are using oral semaglutide and planning to fast during Ramadan. Participants will take oral semaglutide as prescribed by the study doctor. The study will last for about 5 months (20 weeks). Participants will be asked to complete a patient diary about how and when they take the oral semaglutide tablets. Participants will complete this diary during the study period as instructed by study doctor.
    AcronymO-SEMA-Fast
    StatusFinished
    Effective start/end date25/01/239/07/23

    Collaborative partners

    Keywords

    • Glucose Metabolism Disorders
    • Metabolic Diseases
    • Endocrine System Diseases
    • Diabetes Mellitus
    • Diabetes Mellitus, Type 2
    • Glucagon-Like Peptide-1 Receptor Agonists
    • Hypoglycemic Agents
    • Physiological Effects of Drugs
    • Semaglutide

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.